FI62290C - Foerfarande foer framstaellning av pyrrolidinderivat med inverkan pao det centrala nervsystemet - Google Patents

Foerfarande foer framstaellning av pyrrolidinderivat med inverkan pao det centrala nervsystemet Download PDF

Info

Publication number
FI62290C
FI62290C FI762314A FI762314A FI62290C FI 62290 C FI62290 C FI 62290C FI 762314 A FI762314 A FI 762314A FI 762314 A FI762314 A FI 762314A FI 62290 C FI62290 C FI 62290C
Authority
FI
Finland
Prior art keywords
formula
carbon atoms
med
compound
coor
Prior art date
Application number
FI762314A
Other languages
English (en)
Finnish (fi)
Other versions
FI762314A (fr
FI62290B (fi
Inventor
Giorgio Pifferi
Mario Pinza
Original Assignee
Isf Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isf Spa filed Critical Isf Spa
Publication of FI762314A publication Critical patent/FI762314A/fi
Application granted granted Critical
Publication of FI62290B publication Critical patent/FI62290B/fi
Publication of FI62290C publication Critical patent/FI62290C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
FI762314A 1975-08-13 1976-08-12 Foerfarande foer framstaellning av pyrrolidinderivat med inverkan pao det centrala nervsystemet FI62290C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT26326/75A IT1045043B (it) 1975-08-13 1975-08-13 Derivati pirrolidinici
IT2632675 1975-08-13

Publications (3)

Publication Number Publication Date
FI762314A FI762314A (fr) 1977-02-14
FI62290B FI62290B (fi) 1982-08-31
FI62290C true FI62290C (fi) 1982-12-10

Family

ID=11219233

Family Applications (1)

Application Number Title Priority Date Filing Date
FI762314A FI62290C (fi) 1975-08-13 1976-08-12 Foerfarande foer framstaellning av pyrrolidinderivat med inverkan pao det centrala nervsystemet

Country Status (27)

Country Link
US (1) US4118396A (fr)
JP (1) JPS5822034B2 (fr)
AR (1) AR212176A1 (fr)
AT (1) AT353783B (fr)
AU (1) AU506651B2 (fr)
BE (1) BE845099A (fr)
CA (1) CA1077947A (fr)
CH (1) CH624935A5 (fr)
CS (1) CS214766B2 (fr)
DD (1) DD127966B3 (fr)
DE (1) DE2635853C2 (fr)
DK (1) DK156055C (fr)
ES (1) ES450643A1 (fr)
FI (1) FI62290C (fr)
FR (1) FR2320741A1 (fr)
GB (1) GB1550160A (fr)
HU (1) HU173742B (fr)
IN (1) IN144871B (fr)
IT (1) IT1045043B (fr)
MX (1) MX4717E (fr)
NL (1) NL179052C (fr)
NO (1) NO146909C (fr)
NZ (1) NZ181726A (fr)
PL (1) PL101471B1 (fr)
SE (1) SE420599B (fr)
SU (1) SU663302A3 (fr)
YU (1) YU40147B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1075564B (it) * 1977-02-11 1985-04-22 Isf Spa Procedimento per la preparazione di derivati pirrolidinici
IT1075280B (it) 1977-02-11 1985-04-22 Isf Spa Procedimento per la preparazione di derivati pirrolidinici
GB1580559A (en) * 1977-11-24 1980-12-03 Wyeth John & Brother Ltd Amide cerivatives
IT1141287B (it) * 1979-06-13 1986-10-01 Nattermann A & Cie Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
IT1131959B (it) * 1979-08-09 1986-06-25 Hoffmann La Roche Derivati pirrolidinici
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
FR2515179A1 (fr) * 1981-07-24 1983-04-29 Hoffmann La Roche Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
IT1206699B (it) * 1984-02-27 1989-04-27 Isf Spa Procedimento per preparare derivati di pirrolidone.
CH666483A5 (de) * 1985-01-16 1988-07-29 Lonza Ag Verfahren zur herstellung von thiotetronsaeure.
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
EP0223328B1 (fr) 1985-07-26 1992-01-29 Denki Kagaku Kogyo Kabushiki Kaisha Procédé de préparation d'oxiracetam
IL80071A0 (en) * 1985-09-24 1986-12-31 Lonza Ag Pyrrolidine acetamide derivatives
HU195773B (en) * 1985-09-24 1988-07-28 Lonza Ag Process for preparing alkyl esters of 4-alkoxy-3-pyrrolin-2-on-1-yl-acetic acid
CH668423A5 (de) * 1986-06-19 1988-12-30 Lonza Ag Verfahren zur herstellung von 4-alkoxy-3-pyrrolin-2-onen.
US4677114A (en) * 1985-11-22 1987-06-30 Warner-Lambert Company Pyrrolidone-2 derivatives and pharmaceutical compositions thereof
CH668424A5 (de) * 1986-06-26 1988-12-30 Lonza Ag 4-benzyloxy-3-pyrrolin-2-on-l-yl-acetamid, dessen herstellung und verwendung.
CH668422A5 (de) * 1986-06-26 1988-12-30 Lonza Ag 4-benzyloxy-3-pyrrolin-2-on, dessen herstellung und verwendung zur synthese von tetramsaeure.
IT1224168B (it) * 1986-08-01 1990-09-26 Finanziaria R F Spa Ora Finanz Derivati del pirrolidin-2-one ad attivita' nootropa
CH667655A5 (de) * 1986-09-24 1988-10-31 Lonza Ag Verfahren zur herstellung von 4-alkoxy-2(5h)-thiophenonen.
CH670644A5 (fr) * 1986-12-18 1989-06-30 Lonza Ag
CA1305148C (fr) * 1987-08-19 1992-07-14 Hiromu Matsumura Derives de carbamoylpyrrolidone et produits pharmaceutiques pour la demence senile
US5202345A (en) * 1987-08-19 1993-04-13 Shionogi & Co., Ltd. Carbamoylpyrrolidone derivatives and drugs for senile dementia
DE3813416A1 (de) * 1988-04-21 1989-11-02 Hoechst Ag 3,4-dihydroxypyrrolidin-2-on-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
JP2660201B2 (ja) * 1988-08-05 1997-10-08 塩野義製薬株式会社 新規ピロロ［１，４］ベンゾジアゼピン誘導体および老人性痴呆薬
DE58909320D1 (de) * 1988-09-06 1995-08-03 Lonza Ag Verfahren zur Herstellung von 5-Alkyltetramsäuren.
AU625157B2 (en) * 1989-01-17 1992-07-02 F. Hoffmann-La Roche Ag Cyclohexaneacetamide derivatives
FI95034C (fi) * 1989-03-15 1995-12-11 Lonza Ag Menetelmä 1,3-substituoidun tetrahydro-1H-tieno/3,4-d/-imidatsol-2(3H)-on-4-ylideenipentaanihappoesterin valmistamiseksi
CH680293A5 (fr) * 1990-06-26 1992-07-31 Lonza Ag
JP3038032B2 (ja) * 1991-03-25 2000-05-08 日清製粉株式会社 血小板凝集抑制薬
DE60138733D1 (de) 2000-12-28 2009-06-25 Hamilton Pharmaceuticals Inc Arzneimittel zur behandlung und vermeidung neurogener schmerzen
CA2632453A1 (fr) * 2005-12-07 2007-06-14 Ucb Pharma, S.A. Derives de la 3-carboxy-2-0x0-1-pyrrolidine et leurs utilisations
CN107243007A (zh) 2008-10-16 2017-10-13 约翰斯.霍普金斯大学 改善认知功能的方法和组合物
BR112012019923A2 (pt) * 2010-02-09 2016-08-09 Univ Johns Hopkins métodos e composições para melhorar a função cognitiva
CA2891122C (fr) 2012-11-14 2021-07-20 The Johns Hopkins University Methodes et compositions pour le traitement de la schizophrenie
WO2014144663A1 (fr) 2013-03-15 2014-09-18 The Johns Hopkins University Procédés et compositions pour améliorer la fonction cognitive
EP2968220B1 (fr) 2013-03-15 2021-05-05 Agenebio, Inc. Procédés et compositions pour améliorer la fonction cognitive
CN107810002B (zh) 2015-05-22 2021-01-05 艾吉因生物股份有限公司 左乙拉西坦的延时释放药物组合物
CN105820102A (zh) * 2016-05-10 2016-08-03 武汉工程大学 奥拉西坦的合成工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011886B (de) * 1952-04-29 1957-07-11 Waldemar Kutscher Dr Ing Dr Me Verfahren zur Herstellung von Aminoalkylpyrrolen
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
GB1309692A (en) * 1970-02-13 1973-03-14 Ucb Sa N-substituted lactams
US3541111A (en) * 1968-05-08 1970-11-17 Du Pont Pyrrolinecarboxanilide compounds
US3577432A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-phenoxypyrrolidines

Also Published As

Publication number Publication date
ES450643A1 (es) 1977-08-01
DK365176A (da) 1977-02-14
AT353783B (de) 1979-12-10
ATA589476A (de) 1979-05-15
SU663302A3 (ru) 1979-05-15
PL101471B1 (pl) 1978-12-30
NO762791L (fr) 1977-02-15
JPS5822034B2 (ja) 1983-05-06
FI762314A (fr) 1977-02-14
FR2320741A1 (fr) 1977-03-11
FR2320741B1 (fr) 1979-03-02
SE7608938L (sv) 1977-02-14
YU196476A (en) 1982-06-30
GB1550160A (en) 1979-08-08
JPS5223072A (en) 1977-02-21
DK156055B (da) 1989-06-19
NL7608946A (nl) 1977-02-15
BE845099A (fr) 1977-02-11
IN144871B (fr) 1978-07-22
DE2635853C2 (de) 1984-05-30
NZ181726A (en) 1978-09-20
DD127966A5 (de) 1977-10-26
SE420599B (sv) 1981-10-19
NL179052B (nl) 1986-02-03
NO146909C (no) 1982-12-29
FI62290B (fi) 1982-08-31
DK156055C (da) 1989-12-04
DE2635853A1 (de) 1977-02-24
HU173742B (hu) 1979-08-28
IT1045043B (it) 1980-04-21
DD127966B3 (de) 1983-03-30
US4118396A (en) 1978-10-03
CA1077947A (fr) 1980-05-20
AU506651B2 (en) 1980-01-17
AU1679776A (en) 1978-02-16
MX4717E (es) 1982-08-13
NL179052C (nl) 1986-07-01
NO146909B (no) 1982-09-20
CH624935A5 (fr) 1981-08-31
CS214766B2 (en) 1982-05-28
AR212176A1 (es) 1978-05-31
YU40147B (en) 1985-08-31

Similar Documents

Publication Publication Date Title
FI62290C (fi) Foerfarande foer framstaellning av pyrrolidinderivat med inverkan pao det centrala nervsystemet
HRP970560A2 (en) Substituted gamma aminobutyric acids as pharmaceutical agents
EA023990B1 (ru) Разветвленные производные 3-фенилпропионовой кислоты и их применение
PL195520B1 (pl) Enancjomerycznie czyste estry, farmaceutycznie dopuszczalna sól, sposób wytwarzania, środek leczniczy i zastosowanie enancjomerycznie czystych estrów
DD144545A5 (de) Verfahren zur herstellung von neuen tetrahydropyridin-und piperidinderivaten
DE69007603T2 (de) Phenyläthanolaminomethyltetraline, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel.
EP0042100A1 (fr) Dérivés de la pyrazolopyridazine, intermédiaires et leur procédés de préparation, et médicaments les contenant
US5605925A (en) 1-aminoacetamidopyrroles and 1-amino acetamido-2-(substituted) pyrroles and related compounds
WO2013028999A1 (fr) Petites molécules inductrices de gdnf comme nouvelle thérapeutique possible des troubles neuropsychiatriques
DE3650567T2 (de) Medizinische Indol- und Indazol-Ketosulfonderivate
IE56543B1 (en) Process for preparing 4-amino-5-hexenoic acid
NO170976B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylbuten-syrederivater
Bellesia et al. A short approach to chaetomellic anhydride A from 2, 2-dichloropalmitic acid: elucidation of the mechanism governing the functional rearrangement of the chlorinated pyrrolidin-2-one intermediate
Murray et al. An efficient route to the pyrrolizidine ring system via an N-acyl anion cyclisation process
EP0690850A1 (fr) Derives de la morpholine et de la thiomorpholine substitues en position 2 utilises comme antgonistes du gaba b
HRP970509A2 (en) Pyrrolidinyl and pyrrolinylethylamine compounds as kappa agonists
EP0234516B1 (fr) Dérivés de la 1,6-naphtyridine, procédé pour leur préparation et médicament les contenant pour le traitement des maladies cardio-vasculaires
NO762792L (fr)
DK168290B1 (da) 4-Amino-2,3-alkylen-quinolinderivater, en fremgangsmåde til deres fremstilling og anvendelse til fremstilling af et lægemiddel med aktivitet til lettelse af hukommelses-dysfunktion samt farmaceutisk præparat indeholdende et af de nævnte derivater
US8791273B2 (en) 4R,5S-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity
CH620912A5 (fr)
EP0135406A1 (fr) Pyrrolidinones actives sur le système nerveux central, leur procédé de préparation, les médicaments en contenant
GB2023590A (en) 3-amino-2-(5-fluoro and 5- methoxy-1H-indol-3-yl) Propanoic Acid Derivatives and Their Preparation and Use
EP0089926A2 (fr) Préparations pharmaceutiques comprenant des tétracycles contenant de l'azole ainsi que composés de ce type
ITTO960564A1 (it) Derivati diammidici dell'acido antranilico ad attivita' antigastrinica procedimento per la loro preparazione e loro uso farmaceutico.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: I.S.F. S.P.A.